Regresa al Registro Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorCamidge, D. Ross
dc.contributor.authorAhn, Myung-Ju
dc.contributor.authorYang, James C. H.
dc.contributor.authorHan, Ji-Youn
dc.contributor.authorHochmair, Maximilian J.
dc.contributor.authorFelip Font, Enriqueta
dc.contributor.authorKim, Hye Ryun
dc.date.accessioned2021-09-23T11:08:10Z
dc.date.available2021-09-23T11:08:10Z
dc.date.issued2020-11-01
dc.identifier.citationCamidge DR, Kim HR, Ahn MJ, Yang JCH, Han JY, Hochmair MJ, et al. Brigatinib Versus Crizotinib in Advanced ALK Inhibitor–Naive ALK-Positive Non–Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial. J Clin Oncol. 2020 Nov 1;38(31):3592–603.
dc.identifier.issn1527-7755
dc.identifier.urihttps://hdl.handle.net/11351/6346
dc.descriptionCáncer de pulmón; Brigatinib; Estudio ALTA-1L
dc.language.isoeng
dc.publisherAmerican Society of Clinical Oncology
dc.relation.ispartofseriesJournal of Clinical Oncology;38(31)
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectPulmons - Càncer - Tractament
dc.subjectMedicaments antineoplàstics - Ús terapèutic - Eficàcia
dc.subject.meshCarcinoma, Non-Small-Cell Lung
dc.subject.mesh/drug therapy
dc.subject.meshProgression-Free Survival
dc.titleBrigatinib Versus Crizotinib in Advanced ALK Inhibitor–Naive ALK-Positive Non–Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1200/JCO.20.00505
dc.subject.decscarcinoma de pulmón de células no pequeñas
dc.subject.decs/farmacoterapia
dc.subject.decssupervivencia libre de progresión
dc.relation.publishversionhttps://doi.org/10.1200/JCO.20.00505
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Camidge DR] University of Colorado Cancer Center, Aurora, CO. [Kim HR] Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea. [Ahn MJ] Samsung Medical Center, Seoul, South Korea. [Yang JCH] National Taiwan University Hospital, Taipei, Taiwan. [Han JY] National Cancer Center, Goyang, South Korea. [Hochmair MJ] Department of Respiratory and Critical Care Medicine, Krankenhaus Nord–Klinik Floridsdorf, Vienna, Austria. [Felip E] Vall d’Hebron Hospital Universitari, Barcelona, Spain
dc.identifier.pmid32780660
dc.identifier.wos000588411100004
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Regresa al Registro Simple